Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2148624 | Mutation Research/Genetic Toxicology and Environmental Mutagenesis | 2009 | 4 Pages |
Abstract
In the first case-control study on pancreatic cancer conducted on 253 cases and 403 controls in the Czech Republic we observed that the GSTP1-codon 105 Val variant allele and the GSTT1-null genotype were associated with an elevated risk for pancreatic cancer (OR = 1.38; 95%CI = 0.96–1.97 and OR = 1.56; 95%CI = 0.93–2.61, respectively). Combination of GSTT1-null and GSTP1-codon 105 Val variants further increased the risk for pancreatic cancer (OR = 2.50; 95%CI = 1.20–5.20). In conclusion, this study suggests population-specific associations of polymorphisms in key biotransformation genes with elevated risk for pancreatic cancer.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
D. Vrana, H. Pikhart, B. Mohelnikova-Duchonova, I. Holcatova, R. Strnad, A. Slamova, M. Schejbalova, M. Ryska, S. Susova, P. Soucek,